Escitalopram Oxalate (escitalopram) NDC 68645-519

NDC codes

FDA NDC Directory

Product NDC (as listed)68645-519Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68645-0519Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68645-519-54	68645051954	30 TABLET, FILM COATED in 1 BOTTLE (68645-519-54)Marketed from Jun 16, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Escitalopram Oxalate
Generic name (nonproprietary): escitalopram
Active ingredients: Escitalopram oxalate — 10 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Legacy Pharmaceutical Packaging, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078604
Marketing start: Jun 16, 2016
Marketing end: Jun 30, 2027
Other FDA classes: Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 68645-519_4cc2fbda-eb50-c09c-e063-6394a90a9315SPL ID 4cc2fbda-eb50-c09c-e063-6394a90a9315SPL set ID 9c68f89b-1d34-4735-9631-817f012935d7RxCUI 349332, 351250UNII 5U85DBW7LOUPC 0368645519548, 0368645520544
Pharmacologic class: Serotonin Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468645051954 followed by a unit qualifier and the quantity

Package 68645-0519-54. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 11, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Escitalopram is a selective serotonin reuptake inhibitor (SSRI) indicated for the: treatment of major depressive disorder (MDD) in adults and pediatric patients 12 years of age and older (1) treatment of generalized anxiety disorder (GAD) in adults (1) Escitalopram Tablets, USP are indicated for the treatment of: major depressive disorder (MDD) in adults and pediatric patients 12 years of age and older. generalized anxiety disorder (GAD) in adults. Additional pediatric use information is approved for AbbVie Inc.’s LEXAPRO (escitalopram) tablets and LEXAPRO (escitalopram) oral solution. However, due to AbbVie Inc.’s marketing exclusivity rights, this drug product is not labeled with that info…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)